Global Deep brain stimulation (DBS) report from Global Insight Services is the single authoritative source of intelligence on Deep brain stimulation (DBS) market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Deep brain stimulation (DBS) is a surgical procedure used to treat a variety of movement disorders, including Parkinson’s disease, essential tremor, and dystonia. DBS involves implanting a small device called a stimulator in the brain. The stimulator sends electrical impulses to specific areas of the brain, which can help to reduce or eliminate symptoms.
DBS is usually performed as a two-stage procedure. In the first stage, a surgeon makes a small opening in the skull and inserts a thin, flexible wire called a lead into the brain. The lead is then connected to the stimulator, which is implanted under the skin in the chest. In the second stage, the surgeon adjusts the settings on the stimulator to achieve the desired effect.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS21188
Market Segments
The deep brain stimulation devices market report is bifurcated on the basis of product, application, end-user, and region. On the basis of technology, it is segmented into single channel and dual channel. Based on application, it is analyzed across depression, dystonia, Parkinson’s disease, and others. By end-user, it is categorized into hospitals, ambulatory surgical centers, neurological clinics, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.
Key Players
The deep brain stimulation devices market report includes players such as Abbott, Medtronic, Boston Scientific Corp, Aleva Neurotherapeutics S.A., Nexstim, LivaNova PLC, Neuropace Inc., Nevro Corporation, NeuroSigma, Inc., and Cyberonics, Inc.
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS21188
Key Drivers
Deep brain stimulation (DBS) is a surgical procedure in which electrodes are implanted into specific areas of the brain. These electrodes deliver electrical impulses to specific areas of the brain that control movement.
DBS is used to treat a number of different conditions, including Parkinson’s disease, essential tremor, and dystonia. It is also being investigated as a treatment for other conditions such as Alzheimer’s disease, depression, and obsessive-compulsive disorder.
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700